-transparent.png){kind=logo}
Twenty-four patients with chronic utricaria resistant to conventional therapy were treated orally with terbutaline, a specific beta2 stimulant. This therapy was much more effective than antihistamines. At the dose of 1-25 mg three times a day, there were few side effects. The efficacy was independent of the IgE levels; it seemed greater in idiopathic cases than in cholinergic or pressure induced urticaria.
Related Publications
B Kennes, and
J De Maubeuge, and
G Delespesse
March 1971,
British medical journal,
B Kennes, and
J De Maubeuge, and
G Delespesse
September 1975,
Current therapeutic research, clinical and experimental,
B Kennes, and
J De Maubeuge, and
G Delespesse
March 2008,
The British journal of dermatology,
B Kennes, and
J De Maubeuge, and
G Delespesse
January 2005,
Przeglad lekarski,
B Kennes, and
J De Maubeuge, and
G Delespesse
January 1982,
Medicina cutanea ibero-latino-americana,
B Kennes, and
J De Maubeuge, and
G Delespesse
October 1976,
The Journal of tropical medicine and hygiene,
B Kennes, and
J De Maubeuge, and
G Delespesse
January 1952,
Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
B Kennes, and
J De Maubeuge, and
G Delespesse
January 1962,
[Chiryo] [Therapy],
B Kennes, and
J De Maubeuge, and
G Delespesse
April 1966,
Ceskoslovenska dermatologie,
B Kennes, and
J De Maubeuge, and
G Delespesse
September 1986,
Allergie et immunologie,
